1. AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: Rationale and Overview of the Conference

   • Jean-Nicolas Vauthey
   • Elijah Dixon

   CONSENSUS REPORT: RESECTABLE AND BORDERLINE RESECTABLE PANCREAS CANCER 24 April 2009 Pages: 1725 - 1726

2. Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

   • Mark P. Callery
   • Kenneth J. Chang
   • David C. Linehan

   ORIGINAL ARTICLE – CONSENSUS REPORT: RESECTABLE AND BORDERLINE RESECTABLE PANCREAS CANCER 24 April 2009 Pages: 1727 - 1733

3. Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Callery et al.

   • Michael A. Choti
   • Elijah Dixon
   • Douglas Tyler

   Consensus Report: Resectable and Borderline Resectable Pancreas Cancer 24 April 2009 Pages: 1734 - 1735

4. Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

   • Douglas B. Evans
   • Michael B. Farnell
   • Richard D. Schulick

   CONSENSUS REPORT: RESECTABLE AND BORDERLINE RESECTABLE PANCREAS CANCER 23 April 2009 Pages: 1736 - 1744

5. Surgical Treatment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Evans et al.

   • Reid B. Adams
   • Peter J. Allen

   Consensus Report: Resectable and Borderline Resectable Pancreas Cancer 24 April 2009 Pages: 1745 - 1750

6. Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

   • Ross A. Abrams
   • Andrew M. Lowy
   • Peter W. T. Pisters

   CONSENSUS REPORT: RESECTABLE AND BORDERLINE RESECTABLE PANCREAS CANCER 24 April 2009 Pages: 1751 - 1756

7. Editorial: Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Conference

   • Jordan Berlin
   • John P. Hoffman
   • William F. Regine

   CONSENSUS REPORT: RESECTABLE AND BORDERLINE RESECTABLE PANCREAS CANCER Open access 24 April 2009 Pages: 1757 - 1759

8. Centralization of Esophageal Cancer Surgery: The Right Thing to Do Is Seldom Easy

   • Steven DeMeester

   Thoracic Oncology Open access 08 April 2009 Pages: 1760 - 1761

9. Synchronous Colorectal Liver Metastases: Triumph Of Prospective Randomized Trials Over Observational Bias Leads To Paradigm Shift

   • Vijay P. Khatri

   Gastrointestinal Oncology Open access 17 March 2009 Pages: 1762 - 1764

10. Is Laparoscopic Liver Resection Safe and Comparable to Open Liver Resection for Hepatocellular Carcinoma?

    • Kevin Tri Nguyen
    • David A. Geller

    Hepatobiliary and Pancreatic Tumors Open access 02 May 2009 Pages: 1765 - 1767

11. Lymphatic Interrupted: Do We Really Understand the Risks and Consequences?

    • Elizabeth A. Mittendorf
    • Kelly K. Hunt

    Breast Oncology Open access 08 April 2009 Pages: 1768 - 1770

12. Genetics and Personal Genomics for Personalized Breast Cancer Surgery: Progress and Challenges in Research and Clinical Practice

    • Dimosthenis Ziogas
    • Dimitrios H. Roukos

    Breast Oncology 26 March 2009 Pages: 1771 - 1782

13. Genetic Susceptibility to Gastrointestinal Cancer: Minireview of the Genomewide Studies

    • Masayoshi Tokuoka
    • Hideshi Ishii
    • Masaki Mori

    Gastrointestinal Oncology 13 May 2009 Pages: 1783 - 1788

    

14. Centralization of Esophageal Cancer Surgery: Does It Improve Clinical Outcome?

    • M. W. J. M. Wouters
    • H. E. Karim-Kos
    • R. A. E. M. Tollenaar

    Healthcare Policy and Outcomes Open access 16 April 2009 Pages: 1789 - 1798

    

15. Effect of Surgeon Training, Specialization, and Experience on Outcomes for Cancer Surgery: A Systematic Review of the Literature

    • Karl Y. Bilimoria
    • Joseph D. Phillips
    • David J. Bentrem

    Healthcare Policy and Outcomes 15 May 2009 Pages: 1799 - 1808

    

16. Timing of Multimodality Therapy for Resectable Synchronous Colorectal Liver Metastases: A Retrospective Multi-Institutional Analysis

    • Srinevas K. Reddy
    • Daria Zorzi
    • Bryan M. Clary

    Gastrointestinal Oncology 01 November 2008 Pages: 1809 - 1819

    

17. Management of Early Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis

    • Steven C. Cunningham
    • Susan Tsai
    • Timothy M. Pawlik

    Hepatobiliary and Pancreatic Tumors 07 March 2009 Pages: 1820 - 1831

18. Perioperative Factors Affecting Long-Term Outcomes of 473 Consecutive Patients Undergoing Hepatectomy for Hepatocellular Carcinoma

    • Chih-Chi Wang
    • Shridhar G. Iyer
    • Chao-Long Chen

    Hepatobiliary and Pancreatic Tumors 14 April 2009 Pages: 1832 - 1842

    

19. Systematic Subsegmentectomy by Ultrasound-Guided Finger Compression for Hepatocellular Carcinoma in Cirrhosis

    • Guido Torzilli
    • Matteo Donadon
    • Florin Botea

    Multimedia Article 30 April 2009 Pages: 1843 - 1843

20. Response to Neoadjuvant Chemotherapy Does Not Predict Overall Survival for Patients With Synchronous Colorectal Hepatic Metastases

    • David J. Gallagher
    • Junting Zheng
    • Nancy Kemeny

    Hepatobiliary and Pancreatic Tumors 18 February 2009 Pages: 1844 - 1851

    

21. Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion for Unresectable Liver Metastases from Colorectal Center

    • H. Richard Alexander Jr.
    • David L. Bartlett
    • Tatiana H. Beresneva

    Gastrointestinal Oncology 12 May 2009 Pages: 1852 - 1859

    

22. Survival Outcomes of Patients with Colorectal Liver Metastases Following Hepatic Resection or Ablation in the Era of Effective Chemotherapy

    • Mehrdad Nikfarjam
    • Serene Shereef
    • Kevin F. Staveley-O’Carroll

    Hepatobiliary and Pancreatic Tumors 27 November 2008 Pages: 1860 - 1867

    

23. Adjustment of N Stages of Gastric Cancer by the Ratio Between the Metastatic and Examined Lymph Nodes

    • Chan-Young Kim
    • Doo-Hyun Yang

    Gastrointestinal Oncology 12 May 2009 Pages: 1868 - 1874

    

24. Prognostic Significance of Tumor Size in T3 Gastric Cancer

    • Xiaowen Liu
    • Yu Xu
    • Yanong Wang

    Gastrointestinal Oncology 17 April 2009 Pages: 1875 - 1882

    

25. Quality Indicators for Gastric Cancer Surgery: A Survey of Practicing Pathologists in Ontario

    • Alia P. Qureshi
    • C. Andrea Ottensmeyer
    • Natalie G. Coburn

    Gastrointestinal Oncology 07 May 2009 Pages: 1883 - 1889

    

26. Prophylactic Total Gastrectomy (PTG) for Hereditary Diffuse Gastric Cancer (HDGC): The Newfoundland Experience with 23 Patients

    • P. C. Hebbard
    • A. MacMillan
    • D. A. Wirtzfeld

    Gastrointestinal Oncology 01 May 2009 Pages: 1890 - 1895

    

27. Prediction of Recurrence of Early Gastric Cancer After Curative Resection

    • Ji Fu Lai
    • Sungsoo Kim
    • Sung Hoon Noh

    Gastrointestinal Oncology 12 May 2009 Pages: 1896 - 1902

    

28. Long-Term Survival in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: 10 Years of Experience from a Single Institution

    • Terence C. Chua
    • Tristan D. Yan
    • David L. Morris

    Gastrointestinal Oncology 23 April 2009 Pages: 1903 - 1911

    

29. Effect of Age on Survival of Clinical Stage I Non-Small-Cell Lung Cancer

    • Keith Sigel
    • Marcelo Bonomi
    • Juan Wisnivesky

    Healthcare Policy and Outcomes 02 May 2009 Pages: 1912 - 1917

    

30. Potential Increase in the Prognostic Value of p53 Mutation by Pro72 Allele in Stage I Non-Small-Cell Lung Cancer

    • Wen-Pin Chien
    • Ruey-Hong Wong
    • Huei Lee

    Thoracic Oncology 12 May 2009 Pages: 1918 - 1924

31. Prognostic Significance of Phosphorylated FOXO1 Expression in Soft Tissue Sarcoma

    • Binglin Zhang
    • Yasuhiko Tomita
    • Katsuyuki Aozasa

    Bone and Soft Tissue Sarcomas 30 April 2009 Pages: 1925 - 1937

    

32. Valgus Ankle Deformity After Vascularized Fibular Reconstruction for Oncologic Disease

    • Saminathan S. Nathan
    • Edward Athanasian
    • John H. Healey

    Bone and Soft Tissue Sarcomas 02 May 2009 Pages: 1938 - 1945

    

33. Clinicopathological Factors and Nomograms Predicting Nonsentinel Lymph Node Metastases After Neoadjuvant Chemotherapy in Breast Cancer Patients

    • P. Gimbergues
    • C. Abrial
    • J. Dauplat

    Breast Oncology 02 May 2009 Pages: 1946 - 1951

    

34. Predictors of Completion Axillary Lymph Node Dissection in Patients with Positive Sentinel Lymph Nodes

    • Amer K. Karam
    • Meier Hsu
    • Mary L. Gemignani

    Breast Oncology 18 April 2009 Pages: 1952 - 1958

35. The Risk of Developing Arm Lymphedema Among Breast Cancer Survivors: A Meta-Analysis of Treatment Factors

    • Rebecca J. Tsai
    • Leslie K. Dennis
    • Carol Scott-Conner

    Breast Oncology 14 April 2009 Pages: 1959 - 1972

    

36. Recall of and Reactions to a Surgeon Referral Letter for BRCA Genetic Counseling Among High-Risk Breast Cancer Patients

    • Susan T. Vadaparampil
    • Gwendolyn P. Quinn
    • Christine Laronga

    Breast Oncology 30 April 2009 Pages: 1973 - 1981

    

37. Video-Assisted Skin-Sparing Breast-Conserving Surgery for Breast Cancer and Immediate Reconstruction with Autologous Tissue: Clinical Outcomes

    • Hiroo Nakajima
    • Ikuya Fujiwara
    • Junji Magae

    Breast Oncology 24 April 2009 Pages: 1982 - 1989

    

38. Pathological Diagnosis and Cytoreduction of Cardiophrenic Lymph Node and Pleural Metastasis in Ovarian Cancer Patients Using Video-Assisted Thoracic Surgery

    • Myong Cheol Lim
    • Hyun-Sung Lee
    • Sang-Yoon Park

    Gynecologic Oncology 30 April 2009 Pages: 1990 - 1996

    

39. Expression of the Transcription Factor Snail and Its Target Gene Twist Are Associated with Malignancy in Pheochromocytomas

    • Jens Waldmann
    • Emily P. Slater
    • Volker Fendrich

    Endocrine Tumors 02 May 2009 Pages: 1997 - 2005

    

40. Clinical and Pathological Factors Related to ¹⁸F-FDG-PET Positivity in the Diagnosis of Recurrence and/or Metastasis in Patients with Differentiated Thyroid Cancer

    • D. Esteva
    • M. A. Muros
    • T. Muros

    Endocrine Tumors 05 May 2009 Pages: 2006 - 2013

41. Importance of Early Splenectomy in Patients with Hepatosplenic T-Cell Lymphoma and Severe Thrombocytopenia

    • Andrew A. Gumbs
    • Jasmine Zain
    • Owen A. O’Connor

    Medical Oncology 01 May 2009 Pages: 2014 - 2017

    

42. Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM–IMI)

    • Alessandro Testori
    • Gian Luca De Salvo
    • on behalf of the Italian Melanoma Intergroup (IMI)

    Melanomas 09 January 2009 Pages: 2018 - 2027

    

43. Caspase 9 and Caspase 8 Gene Polymorphisms and Susceptibility to Bladder Cancer in North Indian Population

    • Ruchika Gangwar
    • Anil Mandhani
    • Rama Devi Mittal

    Urologic Oncology 02 May 2009 Pages: 2028 - 2034

    

44. Preoperative u-PAR Gene Expression in Bone Marrow Indicates the Potential Power of Recurrence in Breast Cancer Cases

    • Koshi Mimori
    • Akemi Kataoka
    • Masaki Mori

    Translational Research and Biomarkers 30 April 2009 Pages: 2035 - 2041

    

45. Clinicopathologic Significance of KIAA1199 Overexpression in Human Gastric Cancer

    • Shinji Matsuzaki
    • Fumiaki Tanaka
    • Masaki Mori

    Translational Research and Biomarkers 12 May 2009 Pages: 2042 - 2051

    

46. Preoperative Serum Angiopoietin-2 Levels Correlate with Lymph Node Status in Patients with Early Gastric Cancer

    • Min Jung Jo
    • Jun Ho Lee
    • Jae-Moon Bae

    Translational Research and Biomarkers 30 April 2009 Pages: 2052 - 2057

    

47. Dickkopf-1 Expression as a Marker for Predicting Clinical Outcome in Esophageal Squamous Cell Carcinoma

    • Tomoki Makino
    • Makoto Yamasaki
    • Yuichiro Doki

    Translational Research and Biomarkers 30 April 2009 Pages: 2058 - 2064

    

48. Radioimmunotherapy Improves Survival of Rats with Microscopic Liver Metastases of Colorectal Origin

    • Gabie M. de Jong
    • Thijs Hendriks
    • Otto C. Boerman

    Translational Research and Biomarkers Open access 09 May 2009 Pages: 2065 - 2073

    

49. Progress and Limitations of Surgery in Improving Outcomes of Esophagogastric Junction Cancer

    • George E. Chalkiadakis
    • Dimosthenis Ziogas

    Gastrointestinal Oncology 14 April 2009 Pages: 2074 - 2075

50. In Reply: Abdominal-Transhiatal Resection for Adenocarcinoma of the Esophagogastric Junction

    • Fabio Carboni

    Gastrointestinal Oncology 25 April 2009 Pages: 2076 - 2076